About
Savran Technologies develops a non-invasive urine test to predict preeclampsia early in pregnancy, enabling timely clinical intervention to improve maternal and neonatal outcomes.
Explore Savran Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.